Briefing Papers

Cancer52 publishes a briefing paper on the New Cancer Drug Fund Operating Model

On 28th July 2016 Cancer52 published its Cancer52 Position Paper on the new Cancer Drugs Fund Operating Model FINAL 28th July 2016.

 

Cancer52 publishes a briefing paper on England Cancer Strategy Implementation Plan

On 22nd June 2016 Cancer52 published its Cancer52 position statement Cancer Implementation Plan June 2016 FINAL .

 

Cancer52 publishes a briefing paper on Access to Medicines and Treatments

On 23 December 2015,  Cancer52 published its Briefing Paper on Access to Medicines and Treatments.

***********************************

Cancer52 publishes briefing paper on Access to Orphan Medicines in the UK

On 5 June 2014, Cancer52 published its Briefing Paper on Access to Orphan Medicines in the UK.

***********************************

Cancer52 publishes briefing paper on the UK Strategy for Rare Diseases

Making sure that rare cancers aren’t written out of the script

On 24 February 2014, Cancer52 published its briefing paper on the UK Strategy for Rare Diseases.

***********************************

Cancer52 publishes briefing paper on NICE and Value Based Assessment (VBA) 

on 21 February 2014, Cancer52 published its briefing paper  “NICE and Value Based Assessment (VBA) – NICE do it their way.”

***********************************

Cancer52 Briefing Paper on Value Based Pricing and Cancer Drugs Fund

On 20 September 2013, Cancer52 published briefing papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF);  alongside an introductory debate on the topic  amongst leading experts from within the Cancer52 family.

***********************************

Cancer52 Briefing Paper on Value Based Pricing

In November 2012 Cancer52 published its views on Value Based Pricing.

Read the Cancer52 Position Statement on Value Based Pricing 13th November 2012, or feedback comments to jane.lyons@cancer52.org.uk